Pathogenic Intestinal Parasites in Transplant Recipients

  • Joelle I. RosserEmail author
  • Brian G. Blackburn
Living reference work entry


Although a less common cause of gastrointestinal illness in transplant recipients than bacterial or viral etiologies, intestinal parasitic infections can result in severe and prolonged disease in this population. In the developed world, diagnostic delays stemming from low clinical suspicion for intestinal parasites (and the limitations of standard diagnostics) can worsen outcomes in these patients. As travel becomes more frequent among patients both before and after transplant, and with the increasing availability of transplant services globally, clinicians everywhere should be aware of the risk of intestinal parasitic infections in transplant recipients. In this chapter, we review several intestinal protozoans and the diseases they cause in the transplant population, including Cryptosporidium spp., Cyclospora cayetanensis, Cystoisospora belli, Giardia spp., Blastocystis spp., Entamoeba histolytica, Dientamoeba fragilis, and Balantidium coli. We also review several intestinal helminths and the diseases they cause in transplant recipients, including Ascaris lumbricoides, Trichuris trichiura, Capillaria spp., hookworms, and tapeworms.


Protozoa Cryptosporidium spp. Cyclospora cayetanensis Cystoisospora belli Giardia spp. Blastocystis spp. Entamoeba histolytica Dientamoeba fragilis Balantidium coli Helminth Ascaris lumbricoides Ancylostoma spp. Necator americanus Trichuris trichiura Strongyloides stercoralis Capillaria philippinensis Taenia saginata Taenia solium Hymenolepis nana Diphyllobothrium latum Dipylidium caninum Fasciolopsis buski 


  1. 1.
    Minz M, Udgiri N, Heer M, Kashyap R, Malla N. Cryptosporidiosis in live related renal transplant recipients: a single center experience. Transplantation. 2004;77:1916–7. Scholar
  2. 2.
    Silvia F, Simona F, Fabrizio B. Solid organ transplant and parasitic diseases: a review of the clinical cases in the last two decades. Pathogens. 2018;7. Scholar
  3. 3.
    Kılbaș ZG, Yenİcesu M, Araz E, Tanyüksel M. Cyclospora cayetanensis infection in a patient with renal transplant. Türk Hij Ve Deney Biyol Derg. 2009;66:25–7.Google Scholar
  4. 4.
    Delis SG, Tector J, Kato T, Mittal N, Weppler D, Levi D, et al. Diagnosis and treatment of cryptosporidium infection in intestinal transplant recipients. Transplant Proc. 2002;34:951–2. Scholar
  5. 5.
    Pozio E, Rivasi F, Cacci SM. Infection with Cryptosporidium hominis and reinfection with Cryptosporidium parvum in a transplanted ileum. APMIS. 2004;112:309–13. Scholar
  6. 6.
    Kristensen AA, Horneland R, Birn H, Svensson M. Giardia lamblia infection after pancreas-kidney transplantation. BMJ Case Rep. 2016;2016.
  7. 7.
    Gruz F, Fuxman C, Errea A, Tokumoto M, Fernandez A, Velasquez J, et al. Isospora belli infection after isolated intestinal transplant. Transpl Infect Dis. 2010;12:69–72. Scholar
  8. 8.
    Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis Off Publ Infect Dis Soc Am. 1995;21(Suppl 1):S57–61.CrossRefGoogle Scholar
  9. 9.
    Cama VA, Mathison BA. Infections by intestinal Coccidia and Giardia duodenalis. Clin Lab Med. 2015;35:423–44. Scholar
  10. 10.
    Prevention C-C for DC and. CDC – Cryptosporidiosis – fact sheets – a guide to water filters [Internet]. 7 Jan 2019 [cited 16 May 2019]. Available:
  11. 11.
    Florescu DF, Sandkovsky U. Cryptosporidium infection in solid organ transplantation. World J Transplant. 2016;6:460–71. Scholar
  12. 12.
    Barsoum RS. Parasitic infections in transplant recipients. Nat Rev Nephrol. 2006;2:490–503. Scholar
  13. 13.
    Manson’s Tropical Infectious Diseases [Internet]. Elsevier; 2014.
  14. 14.
    McHardy IH, Wu M, Shimizu-Cohen R, Couturier MR, Humphries RM. Detection of intestinal Protozoa in the clinical laboratory. J Clin Microbiol. 2014;52:712–20. Scholar
  15. 15.
    Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53:915–25. Scholar
  16. 16.
    Madison-Antenucci S, Relich RF, Doyle L, Espina N, Fuller D, Karchmer T, et al. Multicenter evaluation of BD max enteric parasite real-time PCR assay for detection of Giardia duodenalis, Cryptosporidium hominis, Cryptosporidium parvum, and Entamoeba histolytica. J Clin Microbiol. 2016;54:2681–8. Scholar
  17. 17.
    Claas EC, Burnham C-AD, Mazzulli T, Templeton K, Topin F. Performance of the xTAG® gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. J Microbiol Biotechnol. 2013;23:1041–5.CrossRefGoogle Scholar
  18. 18.
    Kappagoda S, Singh U, Blackburn BG. Antiparasitic therapy. Mayo Clin Proc. 2011;86:561–83. Scholar
  19. 19.
    Gilbert D, Eliopoulos G, Chambers H, Saag M, Pavia A. The Sanford guide to antimicrobial therapy. 48th ed. Sperryville: Antimicrobial Therapy, Inc.; 2018.Google Scholar
  20. 20.
    Rossignol J-FA, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. 2001;184:103–6. Scholar
  21. 21.
    Abubakar II, Aliyu SH, Arumugam C, Hunter PR, Usman N. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev. 2007;
  22. 22.
    Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant. 2013;13:280–303. Scholar
  23. 23.
    Bhadauria D, Goel A, Kaul A, Sharma RK, Gupta A, Ruhela V, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015;17:48–55. Scholar
  24. 24.
    Ghoshal U, Ranjan P, Dey A, Ghoshal UC. Intestinal cryptosporidiosis in renal transplant recipients: prevalence, species detection and comparative evaluation of SSU rRNA and Cryptosporidium oocyst wall protein genes. Indian J Med Microbiol. 2018;36:247. Scholar
  25. 25.
    Dey A, Ghoshal U, Agarwal V, Ghoshal UC. Genotyping of Cryptosporidium species and their clinical manifestations in patients with renal transplantation and human immunodeficiency virus infection. J Pathog. 2016;2016:2623602. Scholar
  26. 26.
    Raja K, Abbas Z, Hassan SM, Luck NH, Aziz T, Mubarak M. Prevalence of cryptosporidiosis in renal transplant recipients presenting with acute diarrhea at a single center in Pakistan. J Nephropathol. 2014;3:127–31. Scholar
  27. 27.
    Frei P, Weber A, Geier A, Mertens JC, Kohler S, Rogler G, et al. Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis. Transpl Infect Dis. 2011;13:416–8. Scholar
  28. 28.
    Legrand F, Grenouillet F, Larosa F, Dalle F, Saas P, Millon L, et al. Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study. Bone Marrow Transplant. 2011;46:858–62. Scholar
  29. 29.
    Kagawa K, Fujino H, Miki H, Sogabe K, Takahashi M, Maruhashi T, et al. Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: detection of Cryptosporidium oocysts by intestinal biopsies. Transpl Infect Dis. 2018;20:e12826. Scholar
  30. 30.
    Sebastián E, Martín J, McDonald GB, Flores T, Rodríguez A, Blanco A, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant. 2011;46:612–4. Scholar
  31. 31.
    Schiller J, Klein S, Engels M, Büttner R, Rybniker J, Fätkenheuer G, et al. Case report: a Cryptosporidium infection in a patient with relapsed T-lymphoblastic lymphoma undergoing allogeneic stem cell transplantation. Eur J Haematol. 2018;100:383–5. Scholar
  32. 32.
    Gauchotte G, Bressenot A. Colonic cryptosporidiosis in allograft patients: a rare differential diagnosis of acute graft-versus-host disease. Hum Pathol. 2010;41:918–9. Scholar
  33. 33.
    Müller C, Zeiser R, Grüllich C, Finke J, Bertz H, Schmitt-Gräff A, et al. Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. Transplantation. 2004;77:1478–9. Scholar
  34. 34.
    Lanternier F, Amazzough K, Favennec L, Mamzer-Bruneel M-F, Abdoul H, Tourret J, et al. Cryptosporidium spp. infection in solid organ transplantation: the Nationwide “TRANSCRYPTO” study. Transplantation. 2017;101:826–30. Scholar
  35. 35.
    Bonatti H, Barroso LF, Sawyer RG, Kotton CN, Sifri CD. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis Off J Transplant Soc. 2012;14:635–48. Scholar
  36. 36.
    Chieffi PP, Sens YA, Paschoalotti MA, Miorin LA, Silva HG, Jabur P. Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis. Rev Soc Bras Med Trop. 1998;31:333–7.CrossRefGoogle Scholar
  37. 37.
    Turkcapar N, Kutlay S, Nergizoglu G, Atli T, Duman N. Prevalence of Cryptosporidium infection in hemodialysis patients. Nephron. 2002;90:344–6. Scholar
  38. 38.
    Nachbaur D, Kropshofer G, Feichtinger H, Allerberger F, Niederwieser D. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant. 1997;19:1261–3. Scholar
  39. 39.
    Parasitic infections. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2004;4 Suppl 10: 142–155.
  40. 40.
    Campos M, Jouzdani E, Sempoux C, Buts JP, Reding R, Otte JB, et al. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr. 2000;159:113–5.CrossRefGoogle Scholar
  41. 41.
    Denkinger CM, Harigopal P, Ruiz P, Dowdy LM. Cryptosporidium parvum-associated sclerosing cholangitis in a liver transplant patient. Transpl Infect Dis. 2008;10:133–6. Scholar
  42. 42.
    Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, et al. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant. 2003;32:733–7. Scholar
  43. 43.
    Quarello P, Tandoi F, Carraro F, Vassallo E, Pinon M, Romagnoli R, et al. Successful sequential liver and hematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis. Transplantation. 2018;102:823–8. Scholar
  44. 44.
    Casillas SM, Bennett C, Straily A. Notes from the field: multiple Cyclosporiasis outbreaks — United States, 2018. Morb Mortal Wkly Rep. 2018;67:1101–2. Scholar
  45. 45.
    Ortega YR, Sanchez R. Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clin Microbiol Rev. 2010;23:218–34. Scholar
  46. 46.
    Zar FA, El-Bayoumi E, Yungbluth MM. Histologic proof of acalculous cholecystitis due to Cyclospora cayetanensis. Clin Infect Dis. 2001;33:e140–1. Scholar
  47. 47.
    Hoge CW, Shlim DR, Ghimire M, Rabold JG, Pandey P, Walch A, et al. Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet Lond Engl. 1995;345:691–3.CrossRefGoogle Scholar
  48. 48.
    Verdier RI, Fitzgerald DW, Johnson WD, Pape JW. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med. 2000;132:885–8.CrossRefGoogle Scholar
  49. 49.
    Diaz E, Mondragon J, Ramirez E, Bernal R. Epidemiology and control of intestinal parasites with Nitazoxanide in children in Mexico. Am J Trop Med Hyg. 2003;68:384–5. Scholar
  50. 50.
    Bednarska M, Bajer A, Welc-Falęciak R, Pawełas A. Cyclospora cayetanensis infection in transplant traveller: a case report of outbreak. Parasit Vectors. 2015;8:411. Scholar
  51. 51.
    Visvesvara GS, Arrowood MJ, Qvarnstrom Y, Sriram R, Bandea R, Wilkins PP, et al. Concurrent parasitic infections in a renal transplant patient. Emerg Infect Dis. 2013;19:2044–5. Scholar
  52. 52.
    Pape JW, Verdier RI, Boncy M, Boncy J, Johnson WD. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med. 1994;121:654–7.CrossRefGoogle Scholar
  53. 53.
    Pape JW, Verdier RI, Johnson WD. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989;320:1044–7. Scholar
  54. 54.
    HIV/AIDS Treatment Guidelines. In: AIDSinfo [Internet]. [cited 15 May 2019]. Available:
  55. 55.
    Benator DA, French AL, Beaudet LM, Levy CS, Orenstein JM. Isospora belli infection associated with acalculous cholecystitis in a patient with AIDS. Ann Intern Med. 1994;121:663–4.CrossRefGoogle Scholar
  56. 56.
    Bernard E, Delgiudice P, Carles M, Boissy C, Saint-Paul MC, Le Fichoux Y, et al. Disseminated isosporiasis in an AIDS patient. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 1997;16:699–701.CrossRefGoogle Scholar
  57. 57.
    González-Dominguez J, Roldán R, Villanueva JL, Kindelán JM, Jurado R, Torre-Cisneros J. Isospora belli reactive arthritis in a patient with AIDS. Ann Rheum Dis. 1994;53:618–9. Scholar
  58. 58.
    Jayshree RS, Acharya RS, Sridhar H. Isospora belli infection in a patient with acute lymphoblastic leukaemia in India. J Diarrhoeal Dis Res. 1996;14:44–5.PubMedGoogle Scholar
  59. 59.
    Ud Din N, Torka P, Hutchison RE, Riddell SW, Wright J, Gajra A. Severe Isospora (Cystoisospora) belli diarrhea preceding the diagnosis of human T-cell-leukemia-Virus-1-associated T-cell lymphoma. Case Rep Infect Dis. 2012;2012:1. Scholar
  60. 60.
    Resiere D, Vantelon JM, Bourée P, Chachaty E, Nitenberg G, Blot F. Isospora belli infection in a patient with non-Hodgkin’s lymphoma. Clin Microbiol Infect. 2003;9:1065–7. Scholar
  61. 61.
    Meamar AR, Rezaian M, Mirzaei AZ, Zahabiun F, Faghihi AH, Oormazdi H, et al. Severe diarrhea due to Isospora belli in a patient with thymoma. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2009;42:526–9.PubMedGoogle Scholar
  62. 62.
    Akateh C, Arnold CA, Benissan-Messan D, Michaels A, Black SM. Cystoisospora belli gallbladder infection in a liver transplant donor. Case Rep Infect Dis. 2018;2018:1. Scholar
  63. 63.
    Atambay M, Bayraktar MR, Kayabas U, Yilmaz S, Bayindir Y. A rare diarrheic parasite in a liver transplant patient: Isospora belli. Transplant Proc. 2007;39:1693–5. Scholar
  64. 64.
    Yazar S, Tokgöz B, Yaman O, Sahin I. Isospora belli infection in a patient with a renal transplant. Turk Parazitolojii Derg. 2006;30:22–4.Google Scholar
  65. 65.
    Marathe A, Parikh K. Severe diarrhoea due to Cystoisospora belli in renal transplant patient on Immunosuppressive drugs. Indian J Med Microbiol. 2013;31:185. Scholar
  66. 66.
    Koru O, Araz RE, Yilmaz YA, Ergüven S, Yenicesu M, Pektaş B, et al. Case report: Isospora belli infection in a renal transplant recipient. Turk Parazitolojii Derg. 2007;31:98–100.Google Scholar
  67. 67.
    Usluca S, Inceboz T, Unek T, Aksoy U. Isospora belli in a patient with liver transplantation. Turk Parazitolojii Derg. 2012;36:247–50. Scholar
  68. 68.
    Levine GI. Sexually transmitted parasitic diseases. Prim Care. 1991;18:101–28.PubMedGoogle Scholar
  69. 69.
    Moldwin RM. Sexually transmitted protozoal infections. Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia. Urol Clin North Am. 1992;19:93–101.PubMedGoogle Scholar
  70. 70.
    Granados CE, Reveiz L, Uribe LG, Criollo CP. Drugs for treating giardiasis. Cochrane Database Syst Rev. 2012;12:CD007787. Scholar
  71. 71.
    Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clin Infect Dis. 2001;33:22–8. Scholar
  72. 72.
    Escobedo A, Lalle M, Hrastnik N, Rodriguez-Morales AJ, Castro Sanchez EM, Cimerman S, et al. Combination therapy in the management of giardiasis: what laboratory and clinical studies tell us, so far. 2016:205. Scholar
  73. 73.
    Lalle M, Hanevik K. Treatment-refractory giardiasis: challenges and solutions. Infect Drug Resist. 2018;11:1921–33. Scholar
  74. 74.
    Lopez-Velez R, Batlle C, Jiménez C, Navarro M, Norman F, Perez-Molina J. Short course combination therapy for giardiasis after Nitroimidazole failure. Am J Trop Med Hyg. 2010;83:171–3. Scholar
  75. 75.
    Mørch K, Hanevik K, Robertson LJ, Strand EA, Langeland N. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect. 2008;56:268–73. Scholar
  76. 76.
    Valar C, Keitel E, Dal Prá RL, Gnatta D, Santos AF, Bianco PD, et al. Parasitic infection in renal transplant recipients. Transplant Proc. 2007;39:460–2. Scholar
  77. 77.
    Azami M, Sharifi M, Hejazi SH, Tazhibi M. Intestinal parasitic infections in renal transplant recipients. Braz J Infect Dis. 2010;14:15–8. Scholar
  78. 78.
    Bromiker R, Korman SH, Or R, Hardan I, Naparstek E, Cohen P, et al. Severe giardiasis in two patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4:701–3.PubMedGoogle Scholar
  79. 79.
    Ajumobi AB, Daniels JA, Sostre CF, Trevino HH. Giardiasis in a hematopoietic stem cell transplant patient. Transpl Infect Dis. 2014;16:984–7. Scholar
  80. 80.
    Mukku KK, Raju S, Yelanati R. Refractory giardiasis in renal transplantation: a case report. Nephrology. 2015;20:44. Scholar
  81. 81.
    Tan KSW. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639–65. Scholar
  82. 82.
    Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med. 2003;10:128–30. Scholar
  83. 83.
    Rossignol J-F, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2005;3:987–91.Google Scholar
  84. 84.
    Ok UZ, Cirit M, Uner A, Ok E, Akçiçek F, Başçi A, et al. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron. 1997;75:171–4. Scholar
  85. 85.
    Cirioni O, Giacometti A, Drenaggi D, Ancarani F, Scalise G. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol. 1999;15:389–93.CrossRefGoogle Scholar
  86. 86.
    Taşova Y, Sahin B, Koltaş S, Paydaş S. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama. 2000;54:133–6. Scholar
  87. 87.
    Noureldin MS, Shaltout AA, El Hamshary EM, Ali ME. Opportunistic intestinal protozoal infections in immunocompromised children. J Egypt Soc Parasitol. 1999;29:951–61.PubMedGoogle Scholar
  88. 88.
    Ghosh K, Ayyaril M, Nirmala V. Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998;22:1115–7. Scholar
  89. 89.
    Rao K, Sekar U, Iraivan KT, Abraham G, Soundararajan P. Blastocystis hominis–an emerging cause of diarrhoea in renal transplant recipients. J Assoc Physicians India. 2003;51:719–21.PubMedGoogle Scholar
  90. 90.
    Shirley D-AT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for Amebiasis. Open Forum Infect Dis. 2018;5.
  91. 91.
    CDC – DPDx – Amebiasis [Internet]. 9 Jan 2019 [cited 13 Apr 2019]. Available:
  92. 92.
    Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev. 2007;20:511–32. Scholar
  93. 93.
    Shirley D-A, Moonah S. Fulminant amebic colitis after corticosteroid therapy: a systematic review. PLoS Negl Trop Dis. 2016;10:e0004879. Scholar
  94. 94.
    Numata A, Itabashi M, Kishimoto K, Motohashi K, Hagihara M, Kuwabara H, et al. Intestinal amoebiasis in a patient with acute graft-versus-host disease after allogeneic bone marrow transplantation successfully treated by metronidazole. Transpl Infect Dis Off J Transplant Soc. 2015;17:886–9. Scholar
  95. 95.
    Palau LA. First report of invasive amebiasis in an organ transplant recipient. Transplantation. 1997;64:936–7.CrossRefGoogle Scholar
  96. 96.
    Perret C, Harris P, Rivera M, Vial P, Duarte I, Barriga F. Refractory enteric Amebiasis in pediatric patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Pediatr Gastroenterol Nutr. 2000;31:86–90.CrossRefGoogle Scholar
  97. 97.
    Bavaro P, Di Girolamo G, Di Bartolomeo P, Angrilli F, Olioso P, Papalinetti G, et al. Amebiasis after bone marrow transplantation. Bone Marrow Transplant. 1994;13:213–4.PubMedGoogle Scholar
  98. 98.
    Hung C-C, Ji D-D, Sun H-Y, Lee Y-T, Hsu S-Y, Chang S-Y, et al. Increased risk for Entamoeba histolytica infection and invasive Amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis. 2008;2:e175. Scholar
  99. 99.
    Garcia LS. Dientamoeba fragilis, one of the neglected intestinal Protozoa. J Clin Microbiol. 2016;54:2243–50. Scholar
  100. 100.
    Stark D, Barratt J, Chan D, Ellis JT. Dientamoeba fragilis, the neglected Trichomonad of the human bowel. Clin Microbiol Rev. 2016;29:553–80. Scholar
  101. 101.
    Autier B, Belaz S, Razakandrainibe R, Gangneux J-P, Robert-Gangneux F. Comparison of three commercial multiplex PCR assays for the diagnosis of intestinal protozoa. Parasite. 2018;25:48. Scholar
  102. 102.
    van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJJ. Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int J Parasitol Drugs Drug Resist. 2012;2:162–5. Scholar
  103. 103.
    Esteghamati A, Khanaliha K, Bokharaei-Salim F, Sayyahfar S, Ghaderipour M. Prevalence of intestinal parasitic infection in Cancer, organ transplant and primary immunodeficiency patients in Tehran, Iran. Asian Pac J Cancer Prev APJCP. 2019;20:495–501. Scholar
  104. 104.
    Méndez OC, Szmulewicz G, Menghi C, Torres S, González G, Gatta C. Comparison of intestinal parasite infestation indexes among HIV positive and negative populations. Medicina (Mex). 1994;54:307–10.Google Scholar
  105. 105.
    Schuster FL, Ramirez-Avila L. Current world status of Balantidium coli. Clin Microbiol Rev. 2008;21:626–38. Scholar
  106. 106.
    CDC – DPDx – Balantidiasis – Treatment Information [Internet]. [cited 20 May 2019]. Available:
  107. 107.
    Cermeño JR, Hernández De Cuesta I, Uzcátegui O, Páez J, Rivera M, Baliachi N. Balantidium coli in an HIV-infected patient with chronic diarrhoea. AIDS Lond Engl. 2003;17:941–2. Scholar
  108. 108.
    Clyti E, Aznar C, Couppie P, el Guedj M, Carme B, Pradinaud R. A case of coinfection by Balantidium coli and HIV in French Guiana. Bull Soc Pathol Exot. 1998;91:309–11.PubMedGoogle Scholar
  109. 109.
    Anargyrou K, Petrikkos GL, Suller MTE, Skiada A, Siakantaris MP, Osuntoyinbo RT, et al. Pulmonary Balantidium coli infection in a leukemic patient. Am J Hematol. 2003;73:180–3. Scholar
  110. 110.
    Vasilakopoulou A, Dimarongona K, Samakovli A, Papadimitris K, Avlami A. Balantidium coli pneumonia in an immunocompromised patient. Scand J Infect Dis. 2003;35:144–6.CrossRefGoogle Scholar
  111. 111.
    Pawełczyk A, Welc-Falęciak R, Bajer A. Selected aspects of helminth infections Schistosoma sp., Ascaris lumbricoides, Strongyloides stercoralis in individuals diagnosed with human immunodeficiency virus (HIV) infection. Przegl Epidemiol. 2018;72:349–61. Scholar
  112. 112.
    Cooper AJR, Dholakia S, Holland CV, Friend PJ. Helminths in organ transplantation. Lancet Infect Dis. 2017;17:e166–76. Scholar
  113. 113.
    George B, Mathews V, Srivastava A, Chandy M. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant. 2004;33:311. Scholar
  114. 114.
    Amoo JK, Akindele AA, Amoo AOJ, Efunshile AM, Ojurongbe TA, Fayemiwo SA, et al. Prevalence of enteric parasitic infections among people living with HIV in Abeokuta, Nigeria. Pan Afr Med J. 2018;30:66. Scholar
  115. 115.
    Sunil P, Tribhuvan G, Anil M. Ascariasis as a cause of obstructive jaundice in a renal transplant patient. J Nephrol. 2004;17:449–51.PubMedGoogle Scholar
  116. 116.
    Jurcic JG, Koll B, Brown AE, Crown JP, Yahalom J, Gulati SC. Excretion of Ascaris lumbricoides during total body irradiation. Bone Marrow Transplant. 1994;13:491–3.PubMedGoogle Scholar
  117. 117.
    Ozdemir E, Molldrem JJ. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia. Bone Marrow Transplant. 2006;37:785–6. Scholar
  118. 118.
    Huang N-C, Fang H-C, Chou K-J, Chung H-M. Trichuris trichiura: an unusual cause of chronic diarrhoea in a renal transplant patient. Nephrol Dial Transplant. 2003;18:2434–5. Scholar
  119. 119.
    White AC, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and treatment of Neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66:e49–75. Scholar
  120. 120.
    Garcia HH, Lescano AG, Gonzales I, Bustos JA, Pretell EJ, Horton J, et al. Cysticidal efficacy of combined treatment with Praziquantel and Albendazole for parenchymal brain Cysticercosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016;62:1375–9. Scholar
  121. 121.
    Barra Valencia V, Moreno Elola-Olaso A, Fundora Suárez Y, Meneu Díaz JC, de los Galanes SF J, Pérez Saborido B, et al. Second case of neurocysticercosis in a patient with liver transplantation (first case in Spain): a case report. Transplant Proc. 2007;39:2454–7. Scholar
  122. 122.
    Illade L, Molina Angulo B, Solís I, Diaz MÁ, Gonzalez-Vicent M. Neurocysticercosis: an unusual seizure etiology in a hematopoietic stem cell transplanted patient. Pediatr Hematol Oncol. 2018;35:20–2. Scholar
  123. 123.
    Hoare M, Gelson WTH, Antoun N, Alexander GJM. Early recurrence of neurocysticercosis after orthotopic liver transplant. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2006;12:490–1. Scholar
  124. 124.
    Gordillo-Paniagua G, Muñoz-Arizpe R, Ponsa-Molina R. Unusual complication in a patient with renal transplantation: cerebral cysticercosis. Nephron. 1987;45:65–7. Scholar
  125. 125.
    Purvey S, Lu K, Mukkamalla SK, Anandi P, Dumitriu B, Kranick S, et al. Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review. Transpl Infect Dis. 2015;17:456–62. Scholar
  126. 126.
    Rostami MN, Keshavarz H, Eskandari E, Kia EB, Rezaeian M. Intestinal parasitic infections in renal transplant recipients. Iran J Parasitol. 2007;2:16–23.Google Scholar
  127. 127.
    Syafinaz AN, Hamat RA, Malina O, Siti NM, Niazlin MT, Jamal F. Hymenolepis nana in a renal transplant recipient: to treat or not to treat? Med J Malaysia. 2011;66:259–60.PubMedGoogle Scholar
  128. 128.
    Gupta A, Upadhay BK, Khaira A, Bhowmik D, Tiwari SC. Chronic diarrhea caused by Hymenolepis nana in a renal transplant recipient. Clin Exp Nephrol. 2009;13:185–6. Scholar
  129. 129.
    Muehlenbachs A, Bhatnagar J, Agudelo CA, Hidron A, Eberhard ML, Mathison BA, et al. Malignant transformation of Hymenolepis nana in a human host. N Engl J Med. 2015;373:1845–52. Scholar
  130. 130.
    Detrait M, Poirier L, Roy D-C, Kiss T, Busque L, Cohen S, et al. Diphyllobothriasis, a rare cause of profuse diarrhea following autologous transplantation. Bone Marrow Transplant. 2009;44:131–2. Scholar
  131. 131.
    Sahin I, Köz S, Atambay M, Kayabas U, Piskin T, Unal B. A rare cause of diarrhea in a kidney transplant recipient: Dipylidium caninum. Transplant Proc. 2015;47:2243–4. Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Infectious Diseases and Geographic MedicineStanford University School of MedicineStanfordUSA

Section editors and affiliations

  • Cameron R. Wolfe
    • 1
  1. 1.Duke UniversityDurhamUSA

Personalised recommendations